Nobel Biocare Holding AG (Nobel Biocare Holding AG) LT-Debt-to-Total-Asset : 0.16 (As of Dec. 2013)

View and export this data going back to . Start your Free Trial

What is Nobel Biocare Holding AG LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Nobel Biocare Holding AG's long-term debt to total assests ratio for the quarter that ended in Dec. 2013 was 0.16.

Nobel Biocare Holding AG's long-term debt to total assets ratio declined from Dec. 2011 (0.17) to Dec. 2013 (0.16). It may suggest that Nobel Biocare Holding AG is progressively becoming less dependent on debt to grow their business.

Nobel Biocare Holding AG LT-Debt-to-Total-Asset Historical Data

The historical data trend for Nobel Biocare Holding AG's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nobel Biocare Holding AG LT-Debt-to-Total-Asset Chart

Nobel Biocare Holding AG Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.33

0.17

0.16

Nobel Biocare Holding AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial							0.33	-	0.17	0.17	0.16

Nobel Biocare Holding AG LT-Debt-to-Total-Asset Calculation

Nobel Biocare Holding AG's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Dec. 2013 is calculated as

LT Debt to Total Assets (A: Dec. 2013 )	=	Long-Term Debt & Capital Lease Obligation (A: Dec. 2013 )	/	Total Assets (A: Dec. 2013 )
	=	134.551	/	835.514
	=	0.16

Nobel Biocare Holding AG's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2013 is calculated as

LT Debt to Total Assets (Q: Dec. 2013 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2013 )	/	Total Assets (Q: Dec. 2013 )
	=	134.551	/	835.514
	=	0.16

Nobel Biocare Holding AG (OTCPK:NBHGF) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Nobel Biocare Holding AG LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Nobel Biocare Holding AG's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nobel Biocare Holding AG (OTCPK:NBHGF) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

http://www.nobelbiocare.com

Nobel Biocare Holding AG was founded in 2002 in Zurich,Switzerland. The Company offers dental implant systems, high-precision individualized prosthetics and CAD/CAM systems, diagnostics, treatment planning, guided surgery solutions and biomaterials. Its segments include Implant system products and Individualized products. Its geographical segments include United States, Japan, Switzerland, and Other Countries.

Nobel Biocare Holding AG (Nobel Biocare Holding AG) Headlines

From GuruFocus

Mario Gabelli Comments on Nobel Biocare Holding AG

By Vera Yuan Vera Yuan • 10-28-2014

The new NobelProcera� Zirconia Implant Bridge simplifies the partnership between clinicians and technicians

By PRNewswire PRNewswire • 02-08-2021